Neurobiology of addiction and why it is important

Similar documents
Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

Neurobiology of Addiction

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

Understanding Addiction: Why Can t Those Affected Just Say No?

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

substance use and mental disorders: one, the other, or both?

BRAIN MECHANISMS OF REWARD AND ADDICTION

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

The Biology of Addiction

The future of pharmacological treatment.

6B / Boswell, Grant and Slutske Day 2 August 14, 2008

ADHD & Addictions -What We Know

Substance Abuse and Addiction Issues The Science Behind Addiction. John B. Woods. Recovery Specialists, LLC

590,000 deaths can be attributed to an addictive substance in some way

NEUROBIOLOGY ALCOHOLISM

What are Substance Use Disorders?

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

THE STATE OF MEDICINE IN ADDICTION RECOVERY

The Role of Smoking in Cocaine. Addiction

Pharmacotherapy for Substance Use Disorders

Neurobiology of Addiction. Jon E. Grant, JD, MD, MPH Professor University of Chicago

The Neurobiology of Addiction

Key Concepts. Machinery of the Mind. The Growing Cycle. Six Brain Mind Functions. Machinery of the Mind 6/1/2012

Facing Addiction: Key Terms Use Any use of any substance. Driven by market forces. Misuse Use that can harm self or others. Driven by consequences.

Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface

BASIC VOLUME. Elements of Drug Dependence Treatment

Opiate Use Disorder and Opiate Overdose

America is a drugged society

Evidence-Based Treatment Approaches for Gambling Disorder

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

HIV and alcohol use: why is risk reduction in alcohol use important in HIV care?

Understanding Alcohol And Other Drugs Of Abuse

Jay Weiss, MD Drug Summit Little Rock, Arkansas Sep 9/10, 2014

Associate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical

Brain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver

The Adolescent Developmental Stage

The Neurobiology of Addiction. Angela Haliburda, DO

Foundations of Addictions

Management of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur

Drugs, The Brain, and Behavior

What is addiction and what can businesses do about it?

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Treatment Approaches for Drug Addiction

Quick Start Guide for Video Chapter 2: What Is Addiction?

ADDICTIONS. Mine Özmen, M.D. University of İstanbul Cerrahpaşa School of Medicine Department of Psychiatry

The Human Animal Drugs of Plant Origin

UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph

Chapter 7. Screening and Assessment

Understanding Addiction and Dugs Of Abuse

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Update on Medications for Tobacco Cessation

Part IV: Slipping Up: Neuroscience Basis of Relapse & Recovery July 31, am 12:30 pm with Break 10-10:15am

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

Pain and Addiction. Edward Jouney, DO Department of Psychiatry

Do I Have a Drinking Problem?

Alcohol And Mood Disorders. L.E. Smit, MD, FRCPC. Objectives. February 8, 2007

CHAPTER 2. THE NEUROBIOLOGY OF SUBSTANCE USE, MISUSE, AND ADDICTION

Neurobiology of Substance and Gambling Addictions

Drugs, Brain and Behavior

Neurobiology of Addiction. Howard C Wetsman MD,

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

The Neuroscience of Addiction: A mini-review

Linking Neuroscience, Developmental Psychology, and Personal Experience To Help Understand Addiction

Ken Winters, Ph.D. Department of Psychiatry University of Minnesota Midwest Conference on Problem Gambling August 11, 2004

The Nervous System Mark Stanford, Ph.D.

The Biological Perspective. Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo

Vaillant s 4 non-treatment factors. The reward pathway. Carrots and sticks. In a land far, far away

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison

IDDT Fidelity Action Planning Guidelines

Understanding Addiction

Brain Health and Opioid Abuse

Treatment Team Approaches in Substance Abuse Treatment

Brain Reward Pathway and Addiction

Serotonin System May Have Potential as a Target for Cocaine Medications

Tobacco Dependence Treatment From Neurobiology through Public Policy

Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018

Update on Relapse Prevention Medications for Addiction. Outline. A partial catalog of the future. Treatment Misadventures

Neurobiology of Addiction and Recovery. R. Dewayne Book, M.D. Medical Director Fellowship Hall Greensboro, North Carolina

Substance Use Disorders: What Can We Do to Help Break the Cycle of Addiction

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Reframing Addictions

If you give any person a prescription of something like Valium and have them take it on

Knowing How Gamblers Think: Improving Treatment Outcomes

Eighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

The Chronic Disease of Addiction Evidence and Lessons from Practice

Substance Use Disorders: brains, behavior, and diagnosis. Jessica Gregg, MD, PhD OHSU Addiction Medicine Section

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

Pharmacotherapy of Alcohol Use Disorders

Substance Use and Mental Health Disorders: Challenges for Primary Care

Understanding Addiction Implications for Practice

Relevance of craving in eating behaviors

Navigating the. Addiction. A Four-Letter Word!!! What is Addiction? Definition of Addiction: Definition of Addiction: (cont)

Neuroscience for Non-scientists

Transcription:

Neurobiology of addiction and why it is important Stephen Jurd University of Sydney 2016

IF Addiction has a neurobiological basis THEN we should be able to: Define addiction AND Identify relevant neurological systems AND Their molecular pathology AND Manipulate it pharmacologically AND Identify mechanisms of recovery AND Not treat addicts as bad people

Addiction Not simply withdrawal Persists well after use has stopped DSM says early remission to 12 months Common problem Social impact Medical impact Many psychiatric complications

Reward There is a system of reward, hard wired into mammalian brains Attempts to track it down have identified dopamine as the relevant neurotransmitter

The role of dopamine DA is not merely a vector for the production of psychosis DA is crucial for all reinforcement DA in the shell of the nucleus accumbens causes reward = attention, memory and learning Addiction subsumes this basic mechanism

Schematic diagram that represents the dopamine pathway projecting from the ventral tegmental area (VTA) to the nucleus accumbens (NAcc), indicating how substances of abuse can alter the activity of this pathway to produce their rewarding effects.

The Brain Obviously the site of addiction Subtle interplay between various brain functions Wise old Griffith Edwards: salience Responds to stimuli not consciously encoded (Childress et al 2008)

What causes relapse? Stress Cues Priming dose In animals!!!

Addiction neural circuitry (Kalivas and Volkow) Am J Psychiatry. 2012;169(4):351-353. doi:10.1176/appi.ajp.2012.12010041 Copyright American Psychiatric Association. All rights reserved.

The drivers (Volkow, Kob and McLellan 2016) Acutely the experience goes from euphoria to feeling good to escaping dysphoria Abstinence effects go from less energy to less excitement to depression, anxiety, restlessness Preoccupation goes from anticipation to desire to obsession and planning

Behavioural effects Voluntary action with abstinence or control Becomes Flawed control with occasional lapses of taking more than intended, using when unintended Becomes Impulsive action with relapse and compulsive use

Prelude to Passion (Childress 2008) fmri showed limbic activation to unseen cocaine and sexual images of 33 milliseconds duration in 22 male cocaine patients. Brain reward circuitry responds to drug and sexual cues presented outside awareness. 48 hours later, addict liked visible versions of the same cues. This study displays unconscious vulnerability in addiction.

Alcohol Dependence Syndrome Tolerance Repeated withdrawal symptoms Relief of withdrawal by further drinking Salience of drink seeking behaviour Subjective awareness of a compulsion to drink Narrowing of the drinking repertoire Reinstatement after abstinence

Substance Dependence DSM IV Maladaptive pattern of substance use Leading to clinically significant impairment or distress Manifested by three or more criteria Occurring at any time in the same 12 month period

DSM IV Dependence criteria Tolerance Withdrawal Substance taken more or longer than intended Problem cutting down or controlling use Great deal of time spent obtaining, using, recovering from substance Important activities given up or reduced Continued use despite knowledge of harm

DSM 5 criteria As above, but All SUD, no abuse/dependence distinction Only 2 items required Legal consequences out (RBT) Craving in

Genetics 1 Twin studies (Kaij 1961, Prescott 1999) Adoptee studies ( Goodwin 1973, Cloninger 1979, Sigvaardson 1996, Cadoret 1995) Long term follow up (Vaillant 1983, 1995, 2003)

Nano evidence GABA a2 receptor subtypes associated with alcohol dependence (Soyka 2008) A1 allele of D2 DA receptor (Blum & Noble 1990) Serotonin transporter gene(lichterman 2000, Herman et al 2003) Alcohol dehydrogenase (protective)

Old Effective Treatments Opioid substitution ( done, bupe, LAAM) Disulfiram

Newer Treatments Naltrexone Acamprosate (rat model = alcoholisation) Nalmefene Ondansetron Topiramate Baclofen

Latt, Jurd et al (2002)

Sass, Soyka et al

Oh, wait! Wait, Cory!... Add the cereal first and then the milk!

New Drugs - Old Concepts Addiction is a disease Craving is a physical phenomenon Addicts reward themselves chemically

New Drugs - New Concepts Several neurotransmitters are relevant Combination drug treatment may be appropriate There may be pharmacological subtypes of alcohol dependence

1976 status 1992 Status Abstinent Controlled drinking Relapse Dropped out or lost 3+ yrs abs 3+ yrs rtsd 18 3 1 8* 1 7 1 4

NESARC Relapse 2109 people Full remission from alcohol dependence Interviewed 3 years later Recurrence of AUD symptoms in: 51% of asymptomatic risk drinkers 27.2% of low risk drinkers 7.3% abstainers Dawson Goldstein and Grant (2007)

Domino et al (2005) Long term follow up of 292 addict physicians 75% had no relapse over 5 years Relapse more likely if: FH of addiction Dual diagnosis and opioid use Previous relapse

Brewster, Kaufmann et al (2008) Ontario PHP, 5 year follow up of 100 physicians AA/NA a required component 71% no relapse 85% completed program with a good outcome

McLellan, Skipper et al (2008) 5 year follow up data from 16 separate PHPs in USA 75% good outcome at 5 years Much residential treatment and AA

Copyright by The Royal Australian and New Zealand College of Psychiatrists Wile, Frei, Jenkins 2011

Huh? Yes, four slides document 80% recovery How? Close monitoring Big carrots Solid stick

Key components (DuPont) Contingency management Frequent random drug testing Tight links with AA/NA = abstinence Intensified treatment and monitoring follows relapse Continuing care approach Lifelong recovery focus

Independent Factors Substitute Dependencies i.e.habit 53 & 67% New love relationship i.e.love 32 & 38% Religious Involvement i.e.god 49 & 57% Behaviour Modification i.e.control 73 & 49% Percentages for 1 and 3 years abstinent

Full recovery is a reality Securely abstinent subjects had mental health outcomes comparable with those who had never had a drinking problem (Vaillant 1983)

Mental health outcomes HSRS Score Low risk drinker N=227 Abstinent >3 years N=20 Abstinent 1-3 years N=12 0-60 8 0 25 38 Progressiv e alcoholic N=29 60-70 16 30 33 34 70-80 29 40 25 28 80-100 47 30 17 0

Mapping the recovery journeys of former drinkers in recovery Hibbert and Best (2011, Drug and Alcohol Review)

Brain Plasticity Synaptic structures are highly dynamic Synapse count per cell body changes from 2,500 in infants to 15,000 in adolescents to 7,500 in adults Mature brains can generate new neurones Exercise increases neural production Cells move within the CNS

Recovery mechanisms 1 Fellowship Oxytocin Feelgood

Recovery mechanisms 2 Mirror neurones Passive learning Comfort Normalising new behaviour

Recovery mechanisms 3 Anxiety reduction through meditation Chanting Structure Prayer

Recovery The previous slides outline a mechanism for the biological basis of recovery: New behaviours New thoughts New feelings In new cells, synapses and pathways Ultimately, new microscopic neural architecture

SO Addiction lives in the brain And we can: Agree on a definition of addiction AND The relevance of the reward pathway AND Its biochemistry and pathology AND Manipulate it pharmacologically AND Identify a variety of mechanisms relevant to recovery